Cisplatin Injection

Generic name: Pronounced as (sis' pla tin)
Brand names
  • Platinol-AQ®
  • Platinol®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 10/15/2011

Cisplatin injection must be given in a hospital or medical facility under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.

Cisplatin may cause serious kidney problems. Kidney problems may occur more often in older people. Your doctor will order laboratory tests before and during your treatment to see if your kidneys are affected by this medication. Tell your doctor if you have or have ever had kidney disease. Tell your doctor and pharmacist if you are taking aminoglycoside antibiotics such as amikacin (Amikin), gentamicin (Garamycin), or tobramycin (Tobi, Nebcin). If you experience any of the following symptoms, call your doctor immediately: decreased urination; swelling of the face, arms, hands, feet, ankles, or lower legs; or unusual tiredness or weakness.

Cisplatin may cause serious hearing problems, especially in children. Hearing loss may be permanent in some cases. Your doctor will order tests to monitor your hearing before and during your treatment. Tell your doctor and pharmacist if you have ever had radiation therapy to your head. Tell your doctor and pharmacist if you are taking aminoglycoside antibiotics such as amikacin (Amikin), gentamicin (Garamycin), or tobramycin (Tobi, Nebcin). If you experience any of the following symptoms, call your doctor immediately: hearing loss, ringing in the ears, or dizziness.

Cisplatin may cause severe allergic reactions, especially if you have received more than one dose of cisplatin injection. If you experience an allergic reaction to cisplatin injection, it may begin within a few minutes after your infusion starts, and you may experience the following symptoms: hives; skin rash; itching; reddening of the skin; difficulty breathing or swallowing; swelling of the face, throat, tongue, lips; dizziness; faintness; or fast heartbeat. Tell your doctor immediately if you experience any of these symptoms.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests before, during, and after your treatment to check your body's response to cisplatin. Your doctor may need to stop or delay your treatment if you experience certain side effects.

Cisplatin is used combination with other medications to treat cancer of the testicles that has not improved or that has worsened after treatment with other medications or radiation therapy. Cisplatin is used alone or in combination with other medications to treat cancer of the ovaries (cancer that begins in the female reproductive organs where eggs are formed) that has not improved or that has worsened after treatment with other medications or radiation therapy. Cisplatin is also used alone or in combination with other medications to treat bladder cancer that can not be treated with surgery or radiation therapy alone. Cisplatin is in a class of medications known as platinum-containing compounds. It works by stopping or slowing the growth of cancer cells.

Cisplatin injection comes as a solution (liquid) to be injected over 6 to 8 hours intravenously (into a vein) by a doctor or nurse in a medical facility. It is usually given once every 3 to 4 weeks.

Cisplatin is also sometimes used to treat head and neck cancer (including cancer of the mouth, lip, cheek, tongue, palate, throat, tonsils, and sinuses), lung cancer, cancer of the cervix and esophagus, brain tumors, malignant pleural mesothlioma (cancer in the lining of the chest or abdomen), and neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking cisplatin,

  • tell your doctor and pharmacist if you are allergic to cisplatin, carboplatin (Paraplatin), any other medications, or any of the ingredients in cisplatin injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: amphotericin B (Abelcet; AmBisome; Amphotec, Fungizone Intravenous), anticonvulsants such as phenytoin (Dilantin), bumetanide (Bumex), ethacrynic acid (Edecrin), furosemide (Lasix), pyridoxine (Vitamin B-6). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with cisplatin, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have kidney disease or hearing problems. Your doctor may not want you to receive cisplatin injection.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant or breast-feed while you are receiving cisplatin. If you become pregnant while receiving cisplatin, call your doctor. Cisplatin may harm the fetus.

  • Cisplatin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • diarrhea

    • hair loss

    • loss in ability to taste food

    • hiccups

    • dry mouth, dark urine, decreased sweating, dry skin, and other signs of dehydration

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • swelling, pain, redness, or burning at the injection site

    • pain, burning, or tingling in the hands or feet

    • muscle cramps

    • difficulty walking

    • feeling of an electric-like shock when you bend your neck forward

    • seizures

    • sudden changes in vision, including color vision

    • loss of vision

    • eye pain

    • chest pain or pressure

    • fever, sore throat, chills, or other signs of infection

    • unusual bleeding or bruising

    • black and tarry stools

    • red blood in stools

    • bloody vomit

    • vomited material that looks like coffee grounds

  • Cisplatin may increase the risk that you will develop other cancers. Talk to your doctor about the risks of taking this medication.

  • Cisplatin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • decreased urination

  • swelling of the face, arms, hands, feet, ankles, or lower legs

  • unusual tiredness or weakness

  • yellowing of the skin or eyes

  • pain in the upper right part of the stomach

  • nausea

  • vomiting

  • unusual bleeding or bruising

  • hearing problems

  • sudden changes in vision

  • fever, sore throat, chills, or other signs of infection

  • pain, burning, numbness, or tingling in the hands or feet

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • cis-DDP
  • cis-Diamminedichloroplatinum
  • cis-Platinum II
  • DDP

Drug Interaction
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Cisplatin.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Cisplatin is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Cisplatin.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Cisplatin.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Cisplatin.
Cilostazol Cilostazol Cilostazol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Clopidogrel Clopidogrel The serum concentration of Cisplatin can be increased when it is combined with Clopidogrel.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Cisplatin is combined with Mycophenolic acid.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Penbutolol Penbutolol Cisplatin may increase the bradycardic activities of Acebutolol.
Potassium Potassium Cisplatin may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The therapeutic efficacy of Prednisone can be decreased when used in combination with Cisplatin.
Ranitidine Ranitidine The serum concentration of Ranitidine can be increased when it is combined with Cisplatin.
Reserpine Reserpine Cisplatin may decrease the excretion rate of Reserpine which could result in a higher serum level.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Cisplatin.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Etidronic acid.
Triamcinolone Triamcinolone The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Cisplatin.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The serum concentration of Cisplatin can be increased when it is combined with Famotidine.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Cisplatin is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Cisplatin.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cisplatin.
Levofloxacin Injection Levofloxacin Injection Cisplatin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Cisplatin may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The therapeutic efficacy of Methylprednisolone can be decreased when used in combination with Cisplatin.
Metoclopramide Injection Metoclopramide Injection Metoclopramide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Vancomycin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Cisplatin.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cyclosporine Cyclosporine Cisplatin may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Cisplatin.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Cisplatin.
Torsemide Torsemide The risk or severity of ototoxicity and nephrotoxicity can be increased when Torasemide is combined with Cisplatin.
Olanzapine Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Cisplatin.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Cisplatin.
Dofetilide Dofetilide The serum concentration of Dofetilide can be increased when it is combined with Cisplatin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Cisplatin is combined with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Risedronic acid.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Cisplatin is combined with Temozolomide.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Cisplatin.
Desloratadine Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Cisplatin.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Cisplatin is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Cisplatin.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Cisplatin.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Cisplatin.
Glycopyrrolate Glycopyrrolate The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Cisplatin.
Perindopril Perindopril Perindopril may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may increase the nephrotoxic activities of Cisplatin.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Cisplatin is combined with Sirolimus.
Epinephrine Injection Epinephrine Injection The serum concentration of Epinephrine can be increased when it is combined with Cisplatin.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Cisplatin.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Cisplatin.
Zonisamide Zonisamide Zonisamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Cisplatin.
Aripiprazole Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Cisplatin.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Glatiramer.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Cisplatin.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Cisplatin.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Memantine Memantine Cisplatin may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Progesterone Progesterone The serum concentration of Cisplatin can be increased when it is combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Cisplatin.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cisplatin.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Cisplatin.
Duloxetine Duloxetine Duloxetine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Trospium Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Cisplatin.
Bosentan Bosentan The metabolism of Bosentan can be decreased when combined with Cisplatin.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Cisplatin.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Solifenacin Solifenacin The therapeutic efficacy of Solifenacin can be decreased when used in combination with Cisplatin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Cisplatin.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Zoledronic acid.
Adefovir Adefovir Adefovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cisplatin.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cisplatin.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Ibandronate.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Darifenacin Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Cisplatin.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pregabalin Pregabalin Pregabalin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ranolazine Ranolazine The serum concentration of Cisplatin can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Abatacept.
Rasagiline Rasagiline Rasagiline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Imatinib.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Varenicline Varenicline The excretion of Varenicline can be decreased when combined with Cisplatin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Cisplatin.
Albuterol Albuterol Salbutamol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Paliperidone Paliperidone Paliperidone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Cisplatin.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cisplatin.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Cisplatin.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Cisplatin.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Cisplatin.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Oxaliplatin.
Rituximab Injection Rituximab Injection Rituximab may increase the nephrotoxic activities of Cisplatin.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Pemetrexed.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Cisplatin is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of adverse effects can be increased when Sorafenib is combined with Cisplatin.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Sunitinib.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Cisplatin.
Levocetirizine Levocetirizine Levocetirizine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Cisplatin.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Azacitidine.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Cisplatin is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Cisplatin.
Nilotinib Nilotinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Nilotinib.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Cisplatin.
Budesonide Budesonide The therapeutic efficacy of Budesonide can be decreased when used in combination with Cisplatin.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cisplatin.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Decitabine.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Cisplatin.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Nebivolol Nebivolol Cisplatin may increase the bradycardic activities of Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Cisplatin is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Bendamustine.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Cisplatin is combined with Pilocarpine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Cisplatin is combined with Estramustine.
Methylnaltrexone Injection Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Cisplatin.
Midazolam Midazolam Midazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Cisplatin.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Cisplatin.
Milnacipran Milnacipran Milnacipran may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Plerixafor may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fesoterodine Fesoterodine Cisplatin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol Cisplatin may increase the bradycardic activities of Betaxolol.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Cisplatin.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Cisplatin is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The serum concentration of Cisplatin can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Saxagliptin Saxagliptin Saxagliptin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Telavancin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Cisplatin.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Cisplatin.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Cisplatin is combined with Topotecan.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Cisplatin is combined with Pazopanib.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Cisplatin.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Cisplatin.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Cisplatin.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Tocilizumab.
Dalfampridine Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Cisplatin.
Fingolimod Fingolimod Cisplatin may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cisplatin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Cisplatin.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Cisplatin.
Linagliptin Linagliptin The serum concentration of Linagliptin can be increased when it is combined with Cisplatin.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Cisplatin.
Rivaroxaban Rivaroxaban Rivaroxaban may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Cisplatin.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Ruxolitinib.
Vandetanib Vandetanib The serum concentration of Cisplatin can be increased when it is combined with Vandetanib.
Clobazam Clobazam Clobazam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Cisplatin.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Belatacept.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Cisplatin.
Deferiprone Deferiprone Deferiprone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Crizotinib Crizotinib The serum concentration of Cisplatin can be increased when it is combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Melphalan.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Cisplatin is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Cisplatin.
Enzalutamide Enzalutamide Enzalutamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Mirabegron Mirabegron Mirabegron may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The therapeutic efficacy of Corticotropin can be decreased when used in combination with Cisplatin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Cisplatin is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Cisplatin.
Teduglutide Injection Teduglutide Injection Teduglutide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Cisplatin.
Tofacitinib Tofacitinib Cisplatin may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin Alogliptin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Cisplatin is combined with Dimethyl fumarate.
Ponatinib Ponatinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Cisplatin is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Cisplatin.
Canagliflozin Canagliflozin Canagliflozin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Cisplatin.
Trametinib Trametinib Trametinib may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dolutegravir Dolutegravir The serum concentration of Cisplatin can be increased when it is combined with Dolutegravir.
Levomilnacipran Levomilnacipran Levomilnacipran may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Vortioxetine Vortioxetine Vortioxetine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Cisplatin.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Cisplatin is combined with Ibrutinib.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Obinutuzumab.
Sofosbuvir Sofosbuvir Sofosbuvir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Cisplatin.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Cisplatin is combined with Apremilast.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Cisplatin is combined with Idelalisib.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Vorapaxar is combined with Cisplatin.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Cisplatin.
Edoxaban Edoxaban Edoxaban may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Cisplatin is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Blinatumomab.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tasimelteon Tasimelteon Tasimelteon may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Cisplatin is combined with Pirfenidone.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Secukinumab.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Cisplatin is combined with Palbociclib.
Lenvatinib Lenvatinib The serum concentration of Cisplatin can be increased when it is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Cisplatin is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection Haloperidol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amiloride Amiloride The serum concentration of Cisplatin can be increased when it is combined with Amiloride.
Macitentan Macitentan Macitentan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Prednisolone Prednisolone The therapeutic efficacy of Prednisolone can be decreased when used in combination with Cisplatin.
Ziprasidone Injection Ziprasidone Injection The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Cisplatin.
Penicillin G Procaine Injection Penicillin G Procaine Injection Procaine benzylpenicillin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Cisplatin.
Ixazomib Ixazomib Ixazomib may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Lesinurad Lesinurad Lesinurad may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The therapeutic efficacy of Dexamethasone can be decreased when used in combination with Cisplatin.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Cisplatin.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diphenhydramine Injection Diphenhydramine Injection The serum concentration of Diphenhydramine can be increased when it is combined with Cisplatin.
Furosemide Injection Furosemide Injection Furosemide may increase the nephrotoxic and ototoxic activities of Cisplatin.
Lixisenatide Injection Lixisenatide Injection Lixisenatide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) Cisplatin may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Deutetrabenazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Valbenazine Valbenazine Valbenazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Deflazacort Deflazacort The therapeutic efficacy of Deflazacort can be decreased when used in combination with Cisplatin.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Cisplatin.
Naldemedine Naldemedine Naldemedine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Sarilumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Cisplatin can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Benznidazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Delafloxacin Delafloxacin Delafloxacin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Cisplatin.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cisplatin.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Cisplatin.
Apalutamide Apalutamide The serum concentration of Cisplatin can be increased when it is combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Cisplatin is combined with Penicillamine.
Baricitinib Baricitinib The serum concentration of Cisplatin can be increased when it is combined with Baricitinib.
Lofexidine Lofexidine Lofexidine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Cisplatin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Tafenoquine Tafenoquine The serum concentration of Cisplatin can be increased when it is combined with Tafenoquine.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Cisplatin.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Cisplatin.
Stiripentol Stiripentol Stiripentol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Cisplatin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Paclitaxel.
Prucalopride Prucalopride Prucalopride may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Cisplatin.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Cisplatin.
Erdafitinib Erdafitinib The metabolism of Cisplatin can be decreased when combined with Erdafitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Risankizumab.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Cisplatin.
Solriamfetol Solriamfetol Solriamfetol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Cisplatin.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Cisplatin.
Pitolisant Pitolisant Pitolisant may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection Cisplatin can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fosphenytoin Injection Fosphenytoin Injection Cisplatin can cause a decrease in the absorption of Fosphenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Cisplatin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Cisplatin.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Cisplatin.
Cenobamate Cenobamate The metabolism of Cenobamate can be decreased when combined with Cisplatin.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Cisplatin is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Cisplatin.
Tucatinib Tucatinib The serum concentration of Cisplatin can be increased when it is combined with Tucatinib.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Viloxazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Cisplatin.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Cisplatin is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Cisplatin.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Cisplatin.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Cisplatin.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Cisplatin.
Chlorpromazine Chlorpromazine Cisplatin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Diazepam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Flurazepam Flurazepam The serum concentration of Cisplatin can be increased when it is combined with Flurazepam.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The serum concentration of Cisplatin can be increased when it is combined with Phenoxybenzamine.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Cisplatin.
Amantadine Amantadine The serum concentration of Amantadine can be increased when it is combined with Cisplatin.
Codeine Codeine Codeine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Cisplatin is combined with Procarbazine.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Cisplatin.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Cisplatin.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Cisplatin.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methadone Methadone Cisplatin may decrease the excretion rate of Methadone which could result in a higher serum level.
Oxybutynin Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Cisplatin.
Benztropine Benztropine Cisplatin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Maprotiline Maprotiline Cisplatin may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Cisplatin.
Orphenadrine Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Cisplatin.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Cisplatin is combined with Azathioprine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amoxapine Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Cisplatin.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cisplatin.
Hydrocortisone Hydrocortisone The therapeutic efficacy of Cisplatin can be decreased when used in combination with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Cisplatin is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Cisplatin is combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cisplatin is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Cisplatin is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Cisplatin is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Cisplatin may decrease the excretion rate of Phenazopyridine which could result in a higher serum level.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Cisplatin is combined with Carbamazepine.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Prazosin Prazosin The serum concentration of Prazosin can be increased when it is combined with Cisplatin.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cimetidine Cimetidine The serum concentration of Cisplatin can be increased when it is combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Cisplatin.
Clonazepam Clonazepam Clonazepam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Cisplatin.
Promethazine Promethazine Cisplatin may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Cisplatin is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Digoxin Digoxin Cisplatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Chloroquine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Quinine Quinine The serum concentration of Cisplatin can be increased when it is combined with Quinine.
Triamterene Triamterene Triamterene may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Cisplatin.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Cisplatin may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine The serum concentration of Desipramine can be increased when it is combined with Cisplatin.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Imipramine Imipramine The serum concentration of Cisplatin can be increased when it is combined with Imipramine.
Probenecid Probenecid The serum concentration of Cisplatin can be increased when it is combined with Probenecid.
Quinidine Quinidine The serum concentration of Quinidine can be increased when it is combined with Cisplatin.
Procainamide Procainamide The serum concentration of Procainamide can be increased when it is combined with Cisplatin.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Disopyramide Disopyramide The serum concentration of Disopyramide can be increased when it is combined with Cisplatin.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Cisplatin.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Cisplatin.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Cisplatin.
Butabarbital Butabarbital Cisplatin may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Cisplatin is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Cisplatin is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Cisplatin.
Dinoprostone Dinoprostone The serum concentration of Cisplatin can be increased when it is combined with Dinoprostone.
Baclofen Baclofen Cisplatin may decrease the excretion rate of Baclofen which could result in a higher serum level.
Doxylamine Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Cisplatin.
Cyproheptadine Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Cisplatin.
Chlorpheniramine Chlorpheniramine The serum concentration of Cisplatin can be increased when it is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be decreased when combined with Cisplatin.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Cisplatin can be increased when it is combined with Propranolol.
Nortriptyline Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Cisplatin.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Cisplatin is combined with Mercaptopurine.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Cisplatin.
Flavoxate Flavoxate Cisplatin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Fluorouracil.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Cisplatin is combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Cisplatin is combined with Dacarbazine.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Cisplatin.
Pyrantel Pyrantel Pyrantel may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vincristine.
Dipyridamole Dipyridamole The therapeutic efficacy of Cisplatin can be decreased when used in combination with Dipyridamole.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Cisplatin is combined with Vinblastine.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Cisplatin is combined with Bethanechol.
Ethacrynic Acid Ethacrynic Acid The risk or severity of ototoxicity and nephrotoxicity can be increased when Etacrynic acid is combined with Cisplatin.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Metoprolol Metoprolol The serum concentration of Cisplatin can be increased when it is combined with Metoprolol.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Cisplatin.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dicyclomine Dicyclomine Cisplatin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Cisplatin.
Propantheline Propantheline Cisplatin may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The serum concentration of Cisplatin can be increased when it is combined with Trimethoprim.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Cisplatin.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Timolol Timolol Timolol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Verapamil Verapamil Verapamil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Atenolol Atenolol Cisplatin may increase the bradycardic activities of Atenolol.
Pindolol Pindolol Pindolol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Bumetanide Bumetanide The risk or severity of ototoxicity and nephrotoxicity can be increased when Bumetanide is combined with Cisplatin.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Cisplatin.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Cisplatin is combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Cisplatin.
Glipizide Glipizide Glipizide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Indapamide Indapamide Indapamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Gemfibrozil Gemfibrozil Gemfibrozil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Amiodarone Amiodarone The serum concentration of Cisplatin can be increased when it is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Cisplatin.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Cisplatin.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Cisplatin is combined with Clozapine.
Estazolam Estazolam Estazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Cisplatin is combined with Idarubicin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Pentostatin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cisplatin.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Cisplatin.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sotalol Sotalol Cisplatin may increase the bradycardic activities of Sotalol.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Cisplatin.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Cisplatin.
Isradipine Isradipine Isradipine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Cisplatin.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Cisplatin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Cisplatin.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Lamotrigine Lamotrigine The serum concentration of Lamotrigine can be increased when it is combined with Cisplatin.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Cisplatin.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tramadol Tramadol Cisplatin may decrease the excretion rate of Tramadol which could result in a higher serum level.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Cisplatin.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Cisplatin.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Cisplatin.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Cisplatin.
Nicardipine Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Cisplatin.
Bupropion Bupropion The excretion of Cisplatin can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Metformin Metformin The serum concentration of Cisplatin can be increased when it is combined with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Cisplatin.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Lamivudine Lamivudine Cisplatin may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Acarbose may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Cisplatin.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Cisplatin is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cisplatin.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Clomipramine Clomipramine Cisplatin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Cisplatin.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Topiramate Topiramate Topiramate may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Cisplatin.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Cisplatin.
Pramipexole Pramipexole Cisplatin may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Cisplatin.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Cisplatin.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Cisplatin.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Cisplatin.
Propafenone Propafenone Cisplatin may increase the bradycardic activities of Propafenone.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Cisplatin.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Quetiapine Quetiapine Cisplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Paroxetine Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Cisplatin.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Cisplatin.
Efavirenz Efavirenz The metabolism of Efavirenz can be decreased when combined with Cisplatin.
Abacavir Abacavir Abacavir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Cisplatin.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Cisplatin.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Tolterodine Tolterodine Cisplatin may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Cisplatin is combined with Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Cisplatin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists